PCG
NUVB icon

Private Capital Group’s Nuvation Bio NUVB Stock Holding History

Private Capital Group’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$1K Sell
325
-675
-68% -$2.94K ﹤0.01% 1744
2022
Q1 		$5K Hold
1,000
– – ﹤0.01% 1526
2021
Q4 		$9K Buy
+1,000
New +$9.19K ﹤0.01% 1340

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Private Capital Group's NUVB Position: Q2 2022 in Review

Private Capital Group reduced its Nuvation Bio (NUVB) stake by 68% in Q2 2022, selling an estimated $2.94K and leaving 325 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1744.

Private Capital Group first reported a position in NUVB in Q4 2021 and has held it in 3 quarters since. The position peaked at $9K in Q4 2021. 119 funds tracked by Wall St. Rank hold NUVB as of Q2 2022.

  • Private Capital Group held 325 shares of Nuvation Bio worth $1K as of Q2 2022.
  • Private Capital Group sold 675 Nuvation Bio shares in Q2 2022, an estimated $2.94K.
  • Nuvation Bio made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #1744 holding.
  • Private Capital Group first reported a position in Nuvation Bio in Q4 2021 and has held it in 3 quarters since.
  • Private Capital Group's Nuvation Bio position peaked at $9K in Q4 2021.
  • 119 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.